Safety, Tolerability and Pharmacokinetics Study Assessing Ascending Single Oral JTK-853 Doses in Healthy Subjects

NCT01475981 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
70
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Akros Pharma Inc.